These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28391884)

  • 21. Clusterin/Apolipoprotein J immunolocalization on carotid artery is affected by TNF-alpha, cigarette smoking and anti-platelet treatment.
    Yanni AE; Agrogiannis G; Gkekas C; Perrea D
    Lipids Health Dis; 2014 Apr; 13():70. PubMed ID: 24758255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
    Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism.
    Güder G; Hammer F; Deutschbein T; Brenner S; Berliner D; Deubner N; Bidlingmaier M; Ertl G; Allolio B; Angermann CE; Fassnacht M; Störk S
    J Card Fail; 2015 Mar; 21(3):208-16. PubMed ID: 25573831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.
    Ueland T; Dahl CP; Kjekshus J; Hulthe J; Böhm M; Mach F; Goudev A; Lindberg M; Wikstrand J; Aukrust P; Gullestad L
    Circ Heart Fail; 2011 Mar; 4(2):145-52. PubMed ID: 21216833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells.
    Baiersdörfer M; Schwarz M; Seehafer K; Lehmann C; Heit A; Wagner H; Kirschning CJ; Koch-Brandt C
    Exp Cell Res; 2010 Dec; 316(20):3489-500. PubMed ID: 20692254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
    Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
    Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients.
    Traxler D; Lainscak M; Simader E; Ankersmit HJ; Jug B
    Clin Chim Acta; 2017 Oct; 473():127-132. PubMed ID: 28844461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
    Røysland R; Masson S; Omland T; Milani V; Bjerre M; Flyvbjerg A; Di Tano G; Misuraca G; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Am Heart J; 2010 Aug; 160(2):286-93. PubMed ID: 20691834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Nagai T; Nishimura K; Honma T; Higashiyama A; Sugano Y; Nakai M; Honda S; Iwakami N; Okada A; Kawakami S; Kanaya T; Asaumi Y; Aiba T; Nishida Y; Kubota Y; Sugiyama D; Okamura T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
    Eur J Heart Fail; 2016 Jul; 18(7):803-13. PubMed ID: 27126377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival.
    Gotsman I; Keren A; Lotan C; Zwas DR
    J Card Fail; 2012 Sep; 18(9):694-701. PubMed ID: 22939038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
    Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
    Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent decrease of clusterin as a potential cerebrospinal fluid biomarker for drug-resistant epilepsy.
    Yu W; Chen D; Wang Z; Zhou C; Luo J; Xu Y; Shen L; Yin H; Tao S; Xiao Z; Xiao F; Lü Y; Wang X
    J Mol Neurosci; 2014 Sep; 54(1):1-9. PubMed ID: 24488574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of plasma galectin-3 in chronic heart failure patients is maintained when treated with mineralocorticoid receptor antagonists.
    Koukoui F; Desmoulin F; Galinier M; Barutaut M; Caubère C; Evaristi MF; Murat G; De Boer R; Berry M; Smih F; Rouet P
    PLoS One; 2015; 10(3):e0119160. PubMed ID: 25786035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.